These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29490373)

  • 1. Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.
    Lim WY; Morton RL; Turner RM; Jenkins MC; Guitera P; Irwig L; Webster AC; Dieng M; Saw RPM; Low D; Low C; Bell KJL
    JAMA Dermatol; 2018 Apr; 154(4):420-427. PubMed ID: 29490373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial.
    Ackermann DM; Dieng M; Medcalf E; Jenkins MC; van Kemenade CH; Janda M; Turner RM; Cust AE; Morton RL; Irwig L; Guitera P; Soyer HP; Mar V; Hersch JK; Low D; Low C; Saw RPM; Scolyer RA; Drabarek D; Espinoza D; Azzi A; Lilleyman AM; Smit AK; Murchie P; Thompson JF; Bell KJL
    JAMA Dermatol; 2022 Jan; 158(1):33-42. PubMed ID: 34817543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.
    Turner RM; Bell KJ; Morton RL; Hayen A; Francken AB; Howard K; Armstrong B; Thompson JF; Irwig L
    J Clin Oncol; 2011 Dec; 29(35):4641-6. PubMed ID: 22067399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.
    Ackermann DM; Smit AK; Janda M; van Kemenade CH; Dieng M; Morton RL; Turner RM; Cust AE; Irwig L; Hersch JK; Guitera P; Soyer HP; Mar V; Saw RPM; Low D; Low C; Drabarek D; Espinoza D; Emery J; Murchie P; Thompson JF; Scolyer RA; Azzi A; Lilleyman A; Bell KJL
    Trials; 2021 May; 22(1):324. PubMed ID: 33947444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses.
    Ackermann D; Hersch J; Jordan D; Clinton-Gray E; Bracken K; Janda M; Turner R; Bell K
    JMIR Dermatol; 2024 Oct; 7():e58136. PubMed ID: 39418647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of a Hypothetical Reduction in Routinely Scheduled Clinic Visits Among Patients With History of a Localized Melanoma (MEL-SELF): Pilot Randomized Clinical Trial.
    Drabarek D; Ackermann D; Medcalf E; Bell KJL
    JMIR Dermatol; 2023 Jun; 6():e45865. PubMed ID: 37632976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumer Acceptance and Expectations of a Mobile Health Application to Photograph Skin Lesions for Early Detection of Melanoma.
    Koh U; Horsham C; Soyer HP; Loescher LJ; Gillespie N; Vagenas D; Janda M
    Dermatology; 2019; 235(1):4-10. PubMed ID: 30404081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Quality of Relationship Between Patient With Melanoma and Partner on Partner-Assisted Skin Examination Education: A Randomized Clinical Trial.
    Hultgren BA; Turrisi R; Mallett KA; Ackerman S; Robinson JK
    JAMA Dermatol; 2016 Feb; 152(2):184-90. PubMed ID: 26422745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Detection of New Melanomas by Patients With Melanoma and Their Partners Using a Structured Skin Self-examination Skills Training Intervention: A Randomized Clinical Trial.
    Robinson JK; Wayne JD; Martini MC; Hultgren BA; Mallett KA; Turrisi R
    JAMA Dermatol; 2016 Sep; 152(9):979-85. PubMed ID: 27367303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Skin Examination Behaviors and Thinner Nodular vs Superficial Spreading Melanoma at Diagnosis.
    Dessinioti C; Geller AC; Stergiopoulou A; Swetter SM; Baltas E; Mayer JE; Johnson TM; Talaganis J; Trakatelli M; Tsoutsos D; Tsourouflis G; Stratigos AJ
    JAMA Dermatol; 2018 May; 154(5):544-553. PubMed ID: 29710122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
    Damude S; Hoekstra-Weebers JE; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
    Ann Surg Oncol; 2016 Sep; 23(9):2762-71. PubMed ID: 27194552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance.
    Guitera P; Menzies SW; Coates E; Azzi A; Fernandez-Penas P; Lilleyman A; Badcock C; Schmid H; Watts CG; Collgros H; Liu R; van Kemenade C; Mann GJ; Cust AE
    JAMA Dermatol; 2021 May; 157(5):521-530. PubMed ID: 33729464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
    Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
    Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
    JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long-term barriers and facilitators of skin self-examination among individuals diagnosed with melanoma.
    Coroiu A; Moran C; Bergeron C; Drapeau M; Wang B; Kezouh A; Ernst J; Batist G; Körner A
    BMC Cancer; 2020 Feb; 20(1):123. PubMed ID: 32059700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient adherence to skin self-examination. effect of nurse intervention with photographs.
    Oliveria SA; Dusza SW; Phelan DL; Ostroff JS; Berwick M; Halpern AC
    Am J Prev Med; 2004 Feb; 26(2):152-5. PubMed ID: 14751328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redesigning Skin Cancer Early Detection and Care Using a New Mobile Health Application: Protocol of the SKIN Research Project, a Randomised Controlled Trial.
    Janda M; Horsham C; Koh U; Gillespie N; Loescher LJ; Vagenas D; Soyer HP
    Dermatology; 2019; 235(1):11-18. PubMed ID: 30404085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a Skin Self-monitoring Smartphone Application on Time to Physician Consultation Among Patients With Possible Melanoma: A Phase 2 Randomized Clinical Trial.
    Walter FM; Pannebakker MM; Barclay ME; Mills K; Saunders CL; Murchie P; Corrie P; Hall P; Burrows N; Emery JD
    JAMA Netw Open; 2020 Feb; 3(2):e200001. PubMed ID: 32101302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up for cutaneous melanoma].
    Kettelhack C
    Ther Umsch; 2008 Jun; 65(6):335-40. PubMed ID: 18622957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
    Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
    J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.